Clinical Practice Guidance

We are at the forefront of producing and regularly updating internationally renowned guidelines for managing hypertension and cardiovascular disease. These guidelines and clincial practice statements serve as a trusted resource for healthcare professionals, offering evidence-based recommendations to improve patient outcomes.

Explore our comprehensive approach to diagnosis, treatment, and prevention, designed to support better cardiovascular health worldwide.

National Institute for Health & Care Excellence (NICE) Guidance

► Hypertension in adults: diagnosis and management (NICE Guideline NG136)

This guideline covers identifying and treating primary hypertension (high blood pressure) in people aged 18 and over, including people with type 2 diabetes. It aims to reduce the risk of cardiovascular problems such as heart attacks and strokes by helping healthcare professionals to diagnose hypertension accurately and treat it effectively. Read more

Published: 21 November 2023

► Hypertension in pregnancy: diagnosis and management (NICE Guideline NG133)

This guideline covers diagnosing and managing hypertension (high blood pressure), including pre-eclampsia, during pregnancy, labour and birth. It also includes advice for women with hypertension who wish to conceive and women who have had a pregnancy complicated by hypertension. It aims to improve care during pregnancy, labour and birth for women and their babies. Read more

Published: 17 April 2023

Our clinical practice guidance and scientific statements provide healthcare professionals with clear, evidence-based guidance on the prevention, diagnosis, and management of high blood pressure and related health risks. Grounded in the latest scientific research and expert consensus, these statements support clinicians in delivering high-quality, consistent care. They address clinical practice issues such as blood pressure monitoring, treatment thresholds, and emerging therapies, helping ensure that patients receive the most up-to-date and effective interventions.

BIHS Clinical Practice Guidelines

► Investigation and management of resistant hypertension: British and Irish Hypertension Society position statement 2024 read more

► Investigation and management of young-onset hypertension: British and Irish hypertension society position Statement 2024 read more

► Adult hypertension referral pathway and therapeutic management: British and Irish Hypertension Society position statement 2024 read more

► Diagnosis and management of primary hyperaldosteronism in patients with hypertension: a practical approach endorsed by the British and Irish Hypertension Society 2024 read more

► Management of hypertensive crisis: British and Irish Hypertension Society Position document 2022 read more

BIHS Scientific Statements

► British and Irish Hypertension Society response to ‘RAAS inhibitors in pregnancy, breastfeeding and women of childbearing potential: a review of national and international clinical practice guidelines’ 2025 read more

► Specialist Hypertension Clinics: An Essential Pathway but Under-Resourced 2024 read more

► BIHS Statement on NICE Guideline NG238: Cardiovascular disease: risk assessment and reduction, including lipid modification [NG238] 2024 read more

► BIHS Statement on Renal Denervation (RDN) following publication of the NICE Interventional Procedures Guidance IPG754: Percutaneous transluminal renal sympathetic denervation for resistant hypertension 2023 read more

► ABPM and HBPM Keeping Patients Safe. BIHS Statement on infection control in the use of BP monitoring equipment 2021 read more

► BIHS Statement published by the Journal of Human Hypertension 2021

► Fibromuscular dysplasia and hypertension 2020 read more

► Measurement of Blood Pressure in the Leg 2020 read more

► Measurement of blood pressure in people with atrial fibrillation 2019 read more

►The Importance of a Valid Assessment of Salt Intake in Individuals and Populations 2019 read more

►Oscillometric Measurement of Blood Pressure: A Simplified Explanation 2019 read more

►BIHS Statement on Diagnosis of Hypertension in Obese Patients 2017 read more

►BIHS Statement on Aspirin October 2017 read more